• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Prudential Jennison Health Sciences Fund

+ Add to Watchlist

PHLBX:US

40.05 USD 0.24 0.60%

As of 20:00:00 ET on 09/17/2014.

Snapshot for Prudential Jennison Health Sciences Fund (PHLBX)

Year To Date: +15.78% 3-Month: +7.55% 3-Year: +33.04% 52-Week Range: 30.17 - 41.52
1-Month: +2.32% 1-Year: +23.79% 5-Year: +24.09% Beta vs SPR: 0.99

Mutual Fund Chart for PHLBX

No chart data available.
  • PHLBX:US 40.05
  • 1M
  • 1Y
Interactive PHLBX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PHLBX

Prudential Jennison Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of assets plus borrowings for investment purposes in securities of companies in the health sciences sector, such as pharmaceutical, biotechnology and healthcare service providers.

Inception Date: 06-30-1999 Telephone: 1-800-225-1852
Managers: DAVID CHAN / MICHAEL DEL BALSO
Web Site: www.prudentialfunds.com

Fundamentals for PHLBX

NAV (on 2014-09-17) 40.05
Assets (M) (on 2014-08-29) 2,613.95
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 100.00

Dividends for PHLBX

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) 8.06

Fees & Expenses for PHLBX

Front Load 0.00
Back Load 5.00
Current Mgmt Fee 0.73
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 1.88

Top Fund Holdings for PHLBX

Filing Date: 07/31/2014
Name Position Value % of Total
Alexion Pharmaceuticals Inc 722,477 114,866,618 4.844%
BioMarin Pharmaceutical Inc 1,752,708 108,352,409 4.570%
Vertex Pharmaceuticals Inc 1,153,459 102,554,040 4.325%
HCA Holdings Inc 1,356,472 88,591,186 3.736%
Biogen Idec Inc 254,068 84,957,799 3.583%
Roche Holding AG 287,488 83,430,671 3.519%
Incyte Corp 1,607,959 76,490,610 3.226%
Pacira Pharmaceuticals Inc/DE 737,583 67,857,636 2.862%
Intercept Pharmaceuticals Inc 261,624 60,790,953 2.564%
Gilead Sciences Inc 636,020 58,227,631 2.456%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil